CD38 Pretargeted Radioimmunotherapy for Myeloma

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Multiple myeloma and immunoproliferative diseases

Robert M Williams

Multiple Myeloma and Cancer Therapies via Largazole Analogs

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Teru Hideshima

Functional and biologic significance of deacetylase3 inhibition in myeloma

Multiple myeloma and immunoproliferative diseases

Differentiation of Granulocytes and Macrophages

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Kelvin P. Lee

CD28-mediated Regulation of Multiple Myeloma Cell Proliferation and Survival

Multiple myeloma and immunoproliferative diseases